FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS

V2, Crosslink

🧫

FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-fxtas-pe

🧫 Experiment Protocol Validationproposed

SUMMARY

# FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS ## Background and Rationale This experiment addresses a fundamental question in neurogenetics: why only approximately 40% of individuals carrying FMR1 premutation alleles (55-200 CGG repeats) develop Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS), while the remainder remain asymptomatic throughout life. This incomplete penetrance represents a critical knowledge gap with profound implications for genetic c

METHODOLOGY NOTES

**Phase 1: Cohort Recruitment and Characterization (Months 1-6)** • Recruit 500 FMR1 premutation carriers (55-200 CGG repeats) aged 50-85 years through genetics clinics and fragile X family registries • Stratify into affected (n=200, clinically diagnosed FXTAS) and unaffected (n=300, asymptomatic carriers) • Obtain detailed medical histories, family pedigrees, and environmental exposure questionnaires • Collect blood samples for DNA/RNA extraction and establish lymphoblastoid cell lines • Perform comprehensive neurological examinations using standardized FXTAS rating scales **Phase 2: Genetic and Molecular Analysis (Months 4-12)** • Quantify FMR1 CGG repeat lengths using Southern blot and PCR-based methods • Measure FMR1 mRNA levels in blood using qRT-PCR (normalize to GAPDH) • Assess FMRP protein levels via Western blot and immunofluorescence • Conduct genome-wide SNP analysis to identify modifier loci using Illumina arrays • Analyze epigenetic modifications including DNA methylation

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.903199Z'}
summary	# FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS ## Background and Rationale This experiment addresses a fundamental question in neurogenetics: why only approxima
entities	{'genes': ['FXTAS'], 'diseases': ['ALS']}
model_system	human
_schema_version	1
experiment_type	validation
primary_outcome	Validate FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS
methodology_notes	Phase 1: Cohort Recruitment and Characterization (Months 1-6) • Recruit 500 FMR1 premutation carriers (55-200 CGG repeats) aged 50-85 years through genetics clinics and fragile X family registries
replication_status	single_study
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.903204', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

497

Outgoing

445

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutation Carriers Develop FXTAS

derives from (16)

supports (33)

💬 Discussion